Saturday, 15 August 2020


Oramed to list stocks on Nasdaq Capital Market

11 February 2013 | News | By BioSpectrum Bureau

Oramed Pharma common stock will be listed on Nasdaq Capital Market under the symbol ORMP

Oramed Pharma common stock will be listed on Nasdaq Capital Market under the symbol ORMP

Singapore: Israel-based Oramed Pharmaceuticals has received approval from Nasdaq to list its shares of common stock on the Nasdaq Capital Market. The company's shares of common stock will begin trading on the Capital Market under the symbol ORMP (formerly OTCQB: ORMPD) starting from February 11, 2013.

Dr Nadav Kidron, CEO, Oramed, said that, "Oramed is ready to begin trading on a higher profile exchange like Nasdaq. We are very excited and believe that this is the right marketplace for our shares. Listing on Nasdaq should enable us to broaden our investor reach and increase visibility and liquidity of our shares."


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls